Following the news that Pfizer’s vaccine for Covid-19 is showing signs of 90% efficacy, the risk flows have gathered steam across the financial markets, with the latest headlines suggesting that there finally seems to be a light at the end of the pandemic-tunnel.
The American pharma giant said on Tuesday, it will begin a pilot coronavirus immunization program in four US states.
Additional details (via Reuters)
“Launched a pilot program to help better support the states' planning, deployment, and administration of the COVID-19 vaccine candidate.”
“Learnings from the program will be adapted for usage across other states to help them create effective immunization programs for this vaccine.”
“Four states included in the pilot program will not receive vaccine doses earlier than other states by virtue of this pilot.”
On Monday, the risk rally strengthened after Moderna Inc claimed that its experimental vaccine was 94.5% effective, based on interim data from a late-stage clinical trial.
The above reports failed to impress markets, as the Asian equities traded mixed while the futures tied to the S&P 500 index posted small losses.
Meanwhile, the US dollar remained on the back foot across the board, with the DXY losing 0.15% on the day to trade at 92.50.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.